InvestorsHub Logo
Followers 51
Posts 9111
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Sunday, 04/16/2023 11:20:35 PM

Sunday, April 16, 2023 11:20:35 PM

Post# of 13489
additional subgroup analysis data will be presented during a poster session on Tuesday, April 18-


Merck-Moderna vaccine helps reduce chances of skin cancer-

The new results found that 79 percent of participants who received the vaccine and Keytruda stayed cancer-free for 18 months compared to just 62 percent of people who only received Merck’s Keytruda. The companies also said that the results of Phase Two showed mild side effects with the vaccine, like fatigue, injection site pain or chills-
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News